Cargando…
Dexmedetomidine Protects against Airway Inflammation and Airway Remodeling in a Murine Model of Chronic Asthma through TLR4/NF-κB Signaling Pathway
Asthma is a common respiratory disease characterized by chronic airway inflammation. Dexmedetomidine (DEX), a highly selective α2 adrenergic receptor agonist, has been shown to participate in regulating inflammatory states and thus exert organ protective actions. However, the potential of DEX in ast...
Autores principales: | Zhou, Ying, Du, Xiyu, Wang, Qianyu, Xiao, Shilin, Zhi, Juan, Gao, Huibin, Yang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946744/ https://www.ncbi.nlm.nih.gov/pubmed/36846195 http://dx.doi.org/10.1155/2023/3695469 |
Ejemplares similares
-
Dexmedetomidine alleviates airway hyperresponsiveness and allergic airway inflammation through the TLR4/NF-κB signaling pathway in mice
por: Xiao, Shilin, et al.
Publicado: (2022) -
Dexmedetomidine attenuates airway inflammation and oxidative stress in asthma via the Nrf2 signaling pathway
por: Xiao, Shilin, et al.
Publicado: (2022) -
Resveratrol protects against asthma-induced airway inflammation and remodeling by inhibiting the HMGB1/TLR4/NF-κB pathway
por: Jiang, Huanhuan, et al.
Publicado: (2019) -
Evodiamine protects against airway remodelling and inflammation in asthmatic rats by modulating the HMGB1/NF-κB/TLR-4 signalling pathway
por: Wang, Qiong, et al.
Publicado: (2021) -
Ketamine Attenuates Airway Inflammation via Inducing Inflammatory Cells Apoptosis and Activating Nrf2 Pathway in a Mixed-Granulocytic Murine Asthma Model
por: Xiao, Shilin, et al.
Publicado: (2022)